A Proof-Of-Principle Study of Epigenetic Therapy Added to Neoadjuvant Doxorubicin Cyclophosphamide for Locally Advanced Breast Cancer

BACKGROUND: Aberrant DNA methylation and histone deacetylation participate in cancer development and progression; hence, their reversal by inhibitors of DNA methylation and histone deacetylases (HDACs) is at present undergoing clinical testing in cancer therapy. As epigenetic alterations are common...

Descripción completa

Detalles Bibliográficos
Autores principales: Arce, Claudia, Pérez-Plasencia, Carlos, González-Fierro, Aurora, de la Cruz-Hernández, Erick, Revilla-Vázquez, Alma, Chávez-Blanco, Alma, Trejo-Becerril, Catalina, Pérez-Cárdenas, Enrique, Taja-Chayeb, Lucia, Bargallo, Enrique, Villarreal, Patricia, Ramírez, Teresa, Vela, Teresa, Candelaria, Myrna, Camargo, Maria F., Robles, Elizabeth, Dueñas-González, Alfonso
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2006
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1762324/
https://www.ncbi.nlm.nih.gov/pubmed/17183730
http://dx.doi.org/10.1371/journal.pone.0000098

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1762324/
https://www.ncbi.nlm.nih.gov/pubmed/17183730
http://dx.doi.org/10.1371/journal.pone.0000098

Ejemplares similares